Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
Patents for A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution (3,707)
09/2003
09/25/2003DE10214095C1 Producing dedifferentiated, programmable stem cells of human monocytic origin using culture medium having M-CSF and IL-3, useful in treating cirrhosis, pancreatic insufficiency, kidney failure, cardiac infarction and stroke
09/24/2003EP1345968A2 Crystals of whole antibodies and fragments thereof and methods for making and using them
09/18/2003WO2003076475A1 Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring
09/18/2003WO2003076407A1 Novel chalcone derivatives and uses thereof
09/18/2003WO2003075953A2 Immunomodulatory polymeric antigens for treating inflammatory pathogies
09/18/2003US20030176453 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
09/18/2003US20030175881 Nucleic acids encoding (poly) peptides having chips activity
09/18/2003US20030175209 Image diagnosis of a brain tumor, renal carcinoma; tumor treatment therapies, immunotherapy
09/18/2003CA2478921A1 Novel chalcone derivatives and uses thereof
09/17/2003EP1343764A1 Urea and urethane derivatives as integrin inhibitors
09/17/2003EP1343542A2 Carrier with solid fibrinogen and solid thrombin
09/17/2003EP1147119B1 2,3-o-isoproylidene derivatives of monosaccharides as cell adhesion inhibitors
09/16/2003US6620927 Biscarbodiimides, bisthiourea derivatives, bisurea derivatives having a disulfide bond; crosslinking hyaluronic acids and dervivatives to form high viscosity sustained release, drug delivery agents; eye surgery; tissue engineering
09/16/2003CA2172493C Use of angiotensin iii and analogs thereof in tissue repair
09/11/2003US20030171267 Albumin fusion proteins
09/10/2003EP1341754A1 Substituted anthranilic acids
09/10/2003EP1341553A1 Silensed anti-cd28 antibodies and use thereof
09/10/2003EP1341551A2 Treatment of posterior capsule opacification
09/10/2003EP1341543A2 Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
09/04/2003WO2003072159A1 N-{5-[4-(4-methyl-piperazino-methyl)­-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine coated stents
09/04/2003WO2003072027A2 Compositions and formulations of 9- nitrocamptothecin polymorphs and methods of use thereof
09/04/2003WO2003072024A2 Methods of treating vascular disease
09/04/2003WO2001085193A3 Method for promoting neovascularization using a tweak agonist and an angiogenic factor
09/04/2003US20030166671 Amorphous polymorphic forms by grinding or pulverizing; having a distinctive X-ray powder diffraction pattern; anti-tumor and -carcinogenic agents; administered by mouth, intravenous injection and inhalation
09/04/2003CA2477558A1 N-{5-[4-(4-methyl-piperazino-methyl)­-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine coated stents
09/04/2003CA2476630A1 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use thereof
09/04/2003CA2475963A1 Methods of treating vascular disease
09/03/2003EP1339663A2 Naphthalene derivatives
09/03/2003EP1339438A2 Methods for preventing transplant rejection in the eye
09/03/2003CN1440405A Sulfonyl-pyrrolidine derivatives useful for treatment of neurological disorders
09/02/2003US6613739 Immunosuppressants
08/2003
08/28/2003WO2003070188A2 Method of treating trx mediated diseases
08/28/2003CA2476434A1 Method of treating trx mediated diseases
08/26/2003US6610686 Use of pirenoxine for the protection of corneal tissues in photokeractomy
08/21/2003WO2003067979A1 Drugs to be used in organ transplantation
08/21/2003WO2002064748A3 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
08/21/2003WO2002036162A3 Compositions for treatment of ocular neovascularization and neural injury
08/21/2003US20030158409 Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase
08/21/2003US20030158207 N-benzylpiperazine compounds
08/21/2003US20030157084 Methods for preparing purified prostaglandin E synthase
08/20/2003EP1335916A1 Pyridyl-substituted triazoles as tgf inhibitors
08/14/2003WO2003066047A1 Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases
08/14/2003WO2002030445A3 Fibrinogen plus a non-plasmin-acting fibrinolysis inhibitor for the reduction or prevention of adhesion formation
08/14/2003US20030153604 Anticoagulants
08/14/2003US20030153575 Tetracyclic diketopiperazine compounds as pdev inhibitors
08/14/2003US20030153529 Dextrin containing compositions for prevention of adhesions
08/14/2003US20030153524 Including extracellular matrix production and/or deposition, neovascularization, inflammation, cell proliferation, cell migration, associated with connective tissue growth factor by administering agent that decreases expression of the factor
08/14/2003US20030153506 Anticoagulant therapy; multicompartment kits, synergistic effect using the mixtures
08/13/2003EP1334194A2 Imaging, diagnosis and treatment of disease
08/13/2003EP1333809A2 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress
08/13/2003CN1436083A Preparation of pathogen inactivated solution of red blood cells having reduced immunogenicity
08/12/2003US6605593 Enhanced efficacy and reduced toxicity
08/07/2003WO2003064629A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/07/2003WO2003064409A1 Zoniporide mesylate pharmaceutical compositions and processes for improving solubility of zoniporide
08/07/2003WO2003063904A2 Tissue adhesion formation control
08/07/2003WO2003063799A2 Compositions and methods for systemic inhibition of cartilage degradation
08/07/2003US20030149075 Zoniporide mesylate pharmaceutical compositions and processes for improving solubility of zoniporide
08/07/2003US20030149043 N-[(substituted five-membered di-or triaza diunsaturated ring)carbonyl] guanidine derivatives for the treatment of ischemia
08/07/2003US20030148941 Compositions and methods for enhancing analgesic potency of tramadol and attenuating its adverse side effects
08/07/2003CA2474649A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/07/2003CA2472342A1 Zoniporide mesylate pharmaceutical compositions and processes for improving solubility of zoniporide
08/05/2003US6602952 Hydrogels derived from chitosan and poly(ethylene glycol) or related polymers
08/05/2003US6602872 Substituted pyridazines having cytokine inhibitory activity
07/2003
07/31/2003WO2003062467A2 Tissue rejection
07/31/2003WO2003062275A1 Glycoisoforms of adiponectin and uses thereof
07/31/2003WO2003061721A1 Film-forming compositions and methods
07/31/2003WO2003061688A1 Novel analgesics
07/31/2003WO2003061659A1 Treating stress response with chemokine receptor ccr5 modulators
07/31/2003WO2003061652A1 3-(imidazolyl)-2-alkoxypropanoic acids as tafia inhibitors
07/31/2003US20030144293 N-alkyl-adamantyl triazinyl benzamide derivatives
07/31/2003US20030144253 Useful for treating or preventing neuronal damage associated with neurological diseases
07/31/2003CA2476984A1 Lactoferrin as an agent for enhancing action of an opioid
07/31/2003CA2473841A1 Film-forming compositions and methods
07/31/2003CA2473781A1 Glycoisoforms of adiponectin and uses thereof
07/31/2003CA2472682A1 Treating stress response with chemokine receptor ccr5 modulators
07/31/2003CA2472238A1 3-(imidazolyl)-2-alkoxypropanoic acids as tafia inhibitors
07/30/2003EP1330246A1 Use of hydroxyeicosatetraenoic acid derivatives in intraocular surgery
07/30/2003CN1433405A Quinazoline compounds
07/30/2003CN1116044C Antisticking particle and powder containing sodium hyaluronate and their preparation process
07/29/2003CA2076555C Pharmaceuticals for the treatment of rejection reactions in organ transplantations
07/24/2003WO2002030446A3 Reduction or prevention of post-surgical adhesion formation with fibrinogen
07/24/2003US20030139353 Using topoisomerase inhibitor; antiarthritic agents; respiratory system disorders; skin disorders
07/23/2003EP1328622A2 Protein c or activated protein c-like molecules
07/23/2003EP1328552A1 Crosslinked amide derivatives of hyaluronic acid and manufacturing method thereof
07/23/2003CN1432018A Crystalline and amorphous form of triazolo (4,5-d) pyrimidine compound
07/23/2003CN1431998A Growth hormone secretagogues
07/17/2003WO2003057666A2 Inhibitors of dipeptidyl peptidase iv
07/17/2003WO2003057148A2 Use of biomolecular targets in the treatment and visualization of tumors
07/17/2003WO2003057144A2 Change inhibitors of dipeptidyl peptidase iv
07/17/2003CA2471204A1 Inhibitors of dipeptidyl peptidase iv
07/17/2003CA2469480A1 Use of biomolecular targets in the treatment and visualization of tumors
07/16/2003EP1326864A2 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents
07/16/2003EP1326606A2 Ep4 receptor inhibitors to treat rheumatoid arthritis
07/16/2003CN1430511A Method of improving survival of patients
07/16/2003CN1429559A Anti-adhesion isolator
07/15/2003US6593352 2-phenylalkylaminobenzoic acid containing substituted benzylsufamoyl group; useful for treating cardiovascular disorders, and for preserving or storing a transplant for surgery
07/15/2003US6591872 Process and plant for the dynamic packaging of gases, especially those for medical use
07/10/2003WO2003055882A1 Pyrrolopyrimidines as phosphodiesterase vii inhibitors
07/10/2003WO2003055531A2 A hemostatic kit, a method of preparing a hemostatic agent and a method of promoting hemostasis
07/10/2003US20030129240 Polyoxyalkylene block copolymer at desired concentrations with or without a therapeutic agent
1 ... 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 ... 38